Severity of COVID-19 disease is related to hyperactivation and altered migratory capacity of T cells

Spörl S, Kremer AL, Aigner M, Eisenhauer N, Koch P, Meretuk L, Loeffler P, Lutzny-Geier G, Vetter M, Bruns H, Mackensen A, Kremer A, Völkl S (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 118-118

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Silvia Spörl Department of Medicine 5 – Haematology and Oncology Anna-Lena Kremer Professur für Psychosomatik und Psychotherapie Nina Eisenhauer Department of Medicine 5 – Haematology and Oncology Gloria Lutzny-Geier Department of Medicine 5 – Haematology and Oncology Marcel Vetter Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Heiko Bruns Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Andreas Kremer Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Simon Völkl Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Spörl, S., Kremer, A.-L., Aigner, M., Eisenhauer, N., Koch, P., Meretuk, L.,... Völkl, S. (2021). Severity of COVID-19 disease is related to hyperactivation and altered migratory capacity of T cells. In ONCOLOGY RESEARCH AND TREATMENT (pp. 118-118). BASEL: KARGER.

MLA:

Spörl, Silvia, et al. "Severity of COVID-19 disease is related to hyperactivation and altered migratory capacity of T cells." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2021. 118-118.

BibTeX: Download